Registry of Lobbyists
Version 3 of 5 (1999-02-26 to 2000-02-29) was submitted prior to the Lobbying Act coming into force on July 2, 2008. Due to different information requirements at that time, the registration is presented in the following format.
| Corporation: |
NOVOPHARM LIMITED
30 NOVOPHARM COURT TORONTO, ON M1B 2K9 Canada |
| Telephone number: | 416-291-8888 |
| Fax number: | 416-291-2162 |
| Responsible officer name and position during the period of this registration: | DAVID T WINDROSS, VICE-PRESIDENT, GOVERNMENT & PROFESSIONAL AFFAIRS |
| Description of activities: | NOVOPHARM LIMITED IS A CANADIAN BASED GENERIC PHARMACEUTICAL COMPANY. IT HAS OPERATIONS IN SCARBOROUGH, MARKHAM, & STOUFVILLE ONTARIO, DISTRIBUTION CENTRES ACROSS CANADA & ADDITIONAL MANUFACTURING FACILITIES IN WILSON, NORTH CAROLINA, LARGO FLORIDA & HUNGARY. NOVOPHARM EMPLOYS 3000 PEOPLE WORLDWIDE WITH 1600 BASED IN CANADA. OVER 380 GENERIC PRODUCTS ARE MANUFACTURED BY NOVOPHARM - PRESCRIPTION & NON-PRESCRIPTION. NOVOPHARM ALSO OWNS WAMPOLE PHARMACEUTICALS & STANLEY PHARMACEUTICALS WHICH MANUFACTURE & SELL NON-PRESCRIPTION MEDICATIONS.NOVOPHARM IS PRIVATELY OWNED BY LESLIE DAN & WAS FOUNDED IN 1965.IN SUMMARY, NOVOPHARM MANUFACTURES & MARKETS HIGH QUALITY, AFFORDABLE PHARMACEUTICALS IN CANADA & WORLDWIDE. |
| Parent: | The corporation is not a subsidiary of any other parent corporations. |
| Coalition | The corporation is not a member of a coalition. |
| Subsidiary: |
NOVOPHARM BIOTECH INC
147 HAMELIN STREET WINNIPEG, MB Canada R3T 3Z1 STANLEY PHARMACEUTICALS LTD 117 - 260 WEST ESPLANADE NORTH VANCOUVER, BC Canada V7M 3G7 WAMPOLE CANADA INC 1 - 465 MILNER AVENUE TORONTO, ON Canada M1B 2K4 |
| Other direct interests | The corporation's activities are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking. |
| Was the corporation funded in whole or in part by any domestic or foreign government institution in the last completed financial year? | No |
| Federal departments or organizations which have been or will be communicated with during the course of the undertaking: | Environment Canada, Health Canada (HC), Industry Canada, Patented Medicine Prices Review Board (PMPRB), Statistics Canada (StatCan), Treasury Board Of Canada Secretariat (TBS) |
|
Communication techniques that have been used or are expected to be used in the course of the undertaking:
|
Informal communications, Meetings, Presentations, Telephone calls, Written communications, whether in hard copy or electronic format |
| Subject Matter: Areas of Concern: | Consumer Issues, Employment and Training, Environment, Health, Industry, Intellectual Property, International Trade, PHARMACEUTICALS, Science and Technology |
| Subject Matter: Particulars: | BILL C-91 (PATENT ACT) - REVIEW, REGULATIONSGENERIC DRUG APPROVAL PROCESS - HEALTH PROTECTION BRANCHINDUSTRY CANADA - JOB CREATIONPHARMACARE AND HOMECARE PROGRAMSBIOTECHNOLOGY |